StemBioSys Secures $2,662,000 New Funding

  • Feed Type
  • Date
    12/7/2016
  • Company Name
    StemBioSys
  • Mailing Address
    3463 Magic Drive San Antonio, TX 78229 USA
  • Company Description
    BM-HPME offers a number of advantageous benefits. Multiple studies have shown that BM-HPME enhances isolation and provides a higher quantity of usable stem cells, with a higher quality and motility, when compared to cells grown on tissue culture-treated plastic.
  • Website
    http://www.stembiosys.com
  • Transaction Type
    Debt
  • Transaction Amount
    $2,662,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 17 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy

Privacy Preference Center